Her2 Negative Breast Cancer

Featured Health Expert

Taxol Effectiveness: Tempest in a Teapot?

A breast cancer treatment study published in the New England Journal of Medicine this week has the national media hopping–and me wondering why.

The study throws into question the use of Taxol (paclitaxel) as an effective chemotherapy drug for women with HER2-negative, ER-positive (estrogen receptive positive) breast cancer.


Researchers went back and retrieved frozen tissue samples from 1,500 women with breast cancer who were part of a 3,121-participant study back in the ’90s. The original...

Read more

More information on "Her2 Negative Breast Cancer"

From Our Experts

See more SharePosts »

From Our Sources

More on Breast Cancer »